Trevi Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TRVI and other ETFs, options, and stocks.About TRVI
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization Haduvio to treat serious neurologically mediated conditions. It includes treatment of chronic pruritus associated with prurigo nodularis and chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson’s disease.
CEOJennifer L. Good
CEOJennifer L. Good
Employees25
Employees25
HeadquartersNew Haven, Connecticut
HeadquartersNew Haven, Connecticut
Founded2011
Founded2011
Employees25
Employees25
TRVI Key Statistics
Market cap184.12M
Market cap184.12M
Price-Earnings ratio-9.03
Price-Earnings ratio-9.03
Dividend yield—
Dividend yield—
Average volume149.57K
Average volume149.57K
High today$2.87
High today$2.87
Low today$2.57
Low today$2.57
Open price$2.85
Open price$2.85
Volume122.71K
Volume122.71K
52 Week high$4.00
52 Week high$4.00
52 Week low$0.97
52 Week low$0.97
TRVI News
Yahoo Finance 7d
Trevi Therapeutics Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Yahoo FinanceShares of Trevi Therapeutics, Inc. (TRVI) have been struggling lately and have lost 5.5% over the past week. However, a hammer chart pattern was formed in its l...
